Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-031699
Filing Date
2016-10-14
Accepted
2016-10-14 16:05:28
Documents
1
Period of Report
2016-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 18574
  Complete submission text file 0000899243-16-031699.txt   20022
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA CORPORATION PLC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Walker Karin L (Reporting) CIK: 0001559422 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 161937154